Blau Farmacêutica Past Performance

How has Blau Farmacêutica performed over the past 5 years?

Past Performance Score


Past Performance Score 3/6

  • Quality Earnings

  • Growing Profit Margin

  • Earnings Trend

  • Accelerating Growth

  • Earnings vs Industry

  • High ROE


Historical annual earnings growth

Earnings and Revenue History

Quality Earnings: BLAU3 has a high level of non-cash earnings.

Growing Profit Margin: BLAU3's current net profit margins (26.2%) are higher than last year (22.2%).

Past Earnings Growth Analysis

Earnings Trend: BLAU3's earnings have grown significantly by 24.6% per year over the past 5 years.

Accelerating Growth: BLAU3's earnings growth over the past year (17.7%) is below its 5-year average (24.6% per year).

Earnings vs Industry: BLAU3 earnings growth over the past year (17.7%) exceeded the Biotechs industry -7.6%.

Return on Equity

High ROE: BLAU3's Return on Equity (19.1%) is considered low.

Return on Assets

Return on Capital Employed

Discover strong past performing companies